As previously reported, Craig-Hallum analyst Jeff Van Rhee initiated coverage of Cellebrite with a Buy rating and $11 price target. The firm notes that digital forensics is dramatically growing in importance in terms of the prosecution of crime, with digital evidence involved in 90% of cases and cell phones being the most critical. Once data is extracted and reviewed by digital forensics, there is a dire need for analytics and case management for the investigative team and per Craig-Hallum’s work, Cellebrite is proving to be in an ideal position to capture the opportunity. Beyond the existing analytics and case management cross-sell opportunity, the firm sees a broad range of M&A opportunities to incorporate other digital streams of evidence and related management.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLBT:
- Cellebrite initiated with a Buy at Craig-Hallum
- Cellebrite to Report Second-Quarter 2023 Financial Results on August 8, 2023
- Cellebrite price target raised to $6.75 from $6.15 at BofA
- UPDATE – Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations
- Cellebrite Announces Innovative Case-Closing Technology; Raising the Bar for Modern Investigations